Andrew Davies is Market Access Director at the ABHI. His responsibility include working with national and regional bodies to develop systems and processes that enable the NHS to maximise the benefits of innovative technology and adopt best practices.
Key elements of this are ensuring reimbursement, evaluation and adoption mechanisms are aligned and optimized to support access for medical technologies. This is increasingly important for Digital Health technologies and the ability of the UK health system to support and rapidly adopt new digitally enabled technologies and services.
Andrew also leads on Ethics and Compliance for ABHI with responsibility for the Code of Business Practice as well as broader corporate social responsibility issues such as Human Rights and the ethical concerns over AI and data.
Andrew has over 25 years experience in the medical technology sector having worked within MedTech divisions of household names such as Thorn EMI, Philips and Bristol-Myers Squibb. He has held roles covering UK and international marketing, market access and business development across both capital and consumable equipment.
He has a degree in Applied Physics and a post graduate diploma in marketing.
